Closed consultation

Change in legal classification of Nurofen Express 400mg Oral Powder (ARM 86)

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Original consultation

This consultation ran from to

Summary

The MHRA is seeking views on the reclassification from pharmacy to general sale list of Nurofen Express 400mg Oral Powder.

Documents

Consultation description

This consultation seeks your views on the reclassification from pharmacy (P) to general sale list (GSL) of Nurofen Express 400mg Oral Powder.

You are invited to comment on the proposal, a copy of which can be found above. A form for your reply is also attached.

Comments should be sent to Abiodun Aderogba at the MHRA Reclassification Unit.